September 07, 2017
1 min read
Save

Trial Scorecard: ROOBY-FS

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Comparison of interrupted and interrupted apixaban treatment strategies in patients undergoing catheter ablation for nonvalvular AF.

Trial Scorecard: ROOBY-FS